Literature DB >> 8886553

Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM.

A K Turpeinen1, E Vanninen, J T Kuikka, M I Uusitupa.   

Abstract

OBJECTIVE: Global myocardial uptake of 123I-metaiodobenzylguanidine (MIBG) has been shown to be decreased in diabetic patients with autonomic neuropathy, indicating cardiac sympathetic dysfunction. However, possible differences in myocardial MIBG distribution between NIDDM and IDDM diabetic patients are not known. RESEARCH DESIGN AND METHODS: Regional myocardial distribution of 123I-MIBG was studied in seven male IDDM patients (age 45 +/- 2 years, duration of diabetes 30 +/- 3 years, means +/- SE) and 13 NIDDM patients (8 men, 5 women, age 59 +/- 2 years, duration of diabetes 10 +/- 1 years). A dual-tracer single-photon emission tomography was carried out with 123I-MIBG and 99mTc-methoxyisobutylisonitrrile to asses simultaneously myocardial sympathetic innervation and perfusion at rest. Conventional autonomic nervous function tests, power spectral analysis of heart rate variability, and echocardiography were performed for assessments of autonomic function and cardiac dimensions and function.
RESULTS: Autonomic nervous function tests and echocardiography showed similar results in IDDM and NIDDM patients. Despite this, global myocardial MIBG uptake (0.43 +/- 0.04 vs. 0.59 +/- 0.06, P = 0.03) and MIBG heart-to-liver ratio (0.59 +/- 0.03 vs. 0.68 = 0.03, P = 0.05) were lower in NIDDM compared with IDDM patients. Regional distribution of MIBG uptake and regional MIBG/perfusion ratio revealed significantly reduced uptake in NIDDM patients especially in the inferoposterior segments of the left ventricle compared with IDDM patients. Difference in age between NIDDM and IDDM patients did not explain the results.
CONCLUSIONS: Reduced myocardial MIBG uptake was found in NIDDM patients compared with the uptake in IDDM patients, particularly involving inferoposterior segments. Regional sympathetic damage not detectable with conventional autonomic function tests is relatively common in NIDDM.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886553     DOI: 10.2337/diacare.19.10.1083

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  9 in total

Review 1.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

Review 2.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Authors:  Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

3.  Long-term effect of acetyl-L-carnitine on myocardial 123I-MIBG uptake in patients with diabetes.

Authors:  A K Turpeinen; J T Kuikka; E Vanninen; J Yang; M I Uusitupa
Journal:  Clin Auton Res       Date:  2000-02       Impact factor: 4.435

4.  Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability.

Authors:  Arthur J H A Scholte; Joanne D Schuijf; Victoria Delgado; Jurriaan A Kok; Mieke T J Bus; Arie C Maan; Marcel P Stokkel; Antje V Kharagitsingh; Petra Dibbets-Schneider; Ernst E van der Wall; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-22       Impact factor: 9.236

5.  Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients.

Authors:  Daniele Bosone; Roberto Fogari; Matteo Cotta Ramusino; Natascia Ghiotto; Elena Guaschino; Annalisa Zoppi; Angela D'Angelo; Alfredo Costa
Journal:  Heart Vessels       Date:  2016-10-06       Impact factor: 2.037

Review 6.  The management of diabetic neuropathy in CKD.

Authors:  Rodica Pop-Busui; Laurel Roberts; Subramaniam Pennathur; Mathias Kretzler; Frank C Brosius; Eva L Feldman
Journal:  Am J Kidney Dis       Date:  2009-12-30       Impact factor: 8.860

Review 7.  Roles of catechol neurochemistry in autonomic function testing.

Authors:  David S Goldstein; William P Cheshire
Journal:  Clin Auton Res       Date:  2018-04-28       Impact factor: 4.435

8.  Glycemic status, non-traditional risk and left ventricular structure and function in the Jackson Heart Study.

Authors:  Chizobam Ani; David Shavlik; Synnove Knutsen; Islam Abudayyeh; Jimmie Banta; Emily O'Brien; Robert J Mentz; Alain G Bertoni; Gary Fraser
Journal:  BMC Cardiovasc Disord       Date:  2022-04-21       Impact factor: 2.174

9.  A Comparative Assessment of Cardiovascular Autonomic Reflex Testing and Cardiac 123I-Metaiodobenzylguanidine Imaging in Patients with Type 1 Diabetes Mellitus without Complications or Cardiovascular Risk Factors.

Authors:  Triantafyllos Didangelos; Efstratios Moralidis; Eleni Karlafti; Konstantinos Tziomalos; Charalambos Margaritidis; Zisis Kontoninas; Ioannis Stergiou; Maria Boulbou; Marianthi Papagianni; Emmanouel Papanastasiou; Apostolos I Hatzitolios
Journal:  Int J Endocrinol       Date:  2018-03-12       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.